OSI Pharma sues Teva and Mylan over Tarceva patent (AP via Yahoo! Finance)

OSI Pharma sues Teva and Mylan over Tarceva patent (AP via Yahoo! Finance)
OSI Pharmaceuticals Inc. said Friday it is suing Teva Pharmaceutical Industries Ltd. and Mylan Inc. for patent infringement, as the companies are seeking to market a generic version of OSI’s daily cancer pill Tarceva.